Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calum Harvey

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
International Review of Neurobiology|May 27, 2024
Non-coding genome contribution to ALSTobias Moll, Calum Harvey, Elham Alhathli, et al.
Current Opinion in Neurology|August 3, 2021
Advances in the genetic classification of amyotrophic lateral sclerosisJohnathan Cooper-Knock, Calum Harvey, Sai Zhang, et al.
Brain : a Journal of Neurology|November 18, 2021
A review of Mendelian randomization in amyotrophic lateral sclerosisThomas H Julian, Sarah Boddy, Mahjabin Islam, et al.
Ebiomedicine|May 29, 2021
Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypesThomas H Julian, Nicholas Glascow, A Dylan Fisher Barry, et al.
BMC Medical Genomics|January 14, 2025
Evaluation of a biomarker for amyotrophic lateral sclerosis derived from a hypomethylated DNA signature of human motor neuronsCalum Harvey, Alicja Nowak, Sai Zhang, et al.
Research Square|December 9, 2024
Evaluation of a biomarker for amyotrophic lateral sclerosis derived from a hypomethylated DNA signature of human motor neuronsCalum Harvey, Alicja Nowak, Sai Zhang, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2022
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replicationTobias Moll, Valerie Odon, Calum Harvey, et al.
Life Science Alliance|October 14, 2022
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replicationTobias Moll, Valerie Odon, Calum Harvey, et al.
Brain Communications|April 20, 2022
Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosisSarah Boddy, Mahjabin Islam, Tobias Moll, et al.
Cell Systems|June 11, 2022
Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severitySai Zhang, Johnathan Cooper-Knock, Annika K Weimer, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Review of Neurobiology|May 27, 2024
Non-coding genome contribution to ALSTobias Moll, Calum Harvey, Elham Alhathli, et al.
Current Opinion in Neurology|August 3, 2021
Advances in the genetic classification of amyotrophic lateral sclerosisJohnathan Cooper-Knock, Calum Harvey, Sai Zhang, et al.
Brain : a Journal of Neurology|November 18, 2021
A review of Mendelian randomization in amyotrophic lateral sclerosisThomas H Julian, Sarah Boddy, Mahjabin Islam, et al.
Ebiomedicine|May 29, 2021
Physical exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypesThomas H Julian, Nicholas Glascow, A Dylan Fisher Barry, et al.
BMC Medical Genomics|January 14, 2025
Evaluation of a biomarker for amyotrophic lateral sclerosis derived from a hypomethylated DNA signature of human motor neuronsCalum Harvey, Alicja Nowak, Sai Zhang, et al.
Research Square|December 9, 2024
Evaluation of a biomarker for amyotrophic lateral sclerosis derived from a hypomethylated DNA signature of human motor neuronsCalum Harvey, Alicja Nowak, Sai Zhang, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2022
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replicationTobias Moll, Valerie Odon, Calum Harvey, et al.
Life Science Alliance|October 14, 2022
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replicationTobias Moll, Valerie Odon, Calum Harvey, et al.
Brain Communications|April 20, 2022
Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosisSarah Boddy, Mahjabin Islam, Tobias Moll, et al.
Cell Systems|June 11, 2022
Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severitySai Zhang, Johnathan Cooper-Knock, Annika K Weimer, et al.
Pageof 3